Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures
Crossref DOI link: https://doi.org/10.1007/s00198-017-4108-y
Published Online: 2017-06-06
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lehmann, T.
Aeberli, D.
License valid from 2017-06-06